Health Economics Review, 2016 6:7 -Published: 11 February 2016
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatment should be to achieve and maintain control of the... disease, as well as to minimize the risks (of exacerbations, disease instability, accelerated loss of lung function, and adverse treatment effects). That requires an approach that is personalized in terms of the pharmacological treatment, patient education, written action plan, training in correct inhaler use, and review of the inhaler technique at each office visit. A panel of 22 pulmonologists was invited to perform a critical review of recent evidence of pharmacological treatment of asthma and to prepare this set of recommendations, a treatment guide tailored to use in Brazil. The topics or questions related to the most significant changes in concepts, and consequently in the management of asthma in clinical practice, were chosen by a panel of experts. To formulate these recommendations, we asked each expert to perform a critical review of a topic or to respond to a question, on the basis of evidence in the literature. In a second phase, three experts discussed and structured all texts submitted by the others. That was followed by a third phase, in which all of the experts reviewed and discussed each recommendation. These recommendations, which are intended for physicians involved in the treatment of asthma, apply to asthma patients of all ages.
more
Dispatches
DOI: http://dx.doi.org/10.3201/eid2203.151607
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 22, No. 3, March 2016
Исследование этого года основано на предыдущем отчете. В нем отслеживается утверждение последних стратегий, руководств и методов в пяти сферах: диагностика и иссл...едование лекарственной устойчивости, режимы лечения лекарственно-чувствительного туберкулеза и туберкулеза с МЛУ, модели лечения и нормативная база.
more
From raising awareness to building capacity
Meeting Report
World Health Organization, Geneva, Switzerland 16 -18 September 2013
Bei vielen schwer erkrankten Menschen muss mit einer im Verhältnis zu anderen schweren ARE längeren Behandlung mit Beatmung/zusätzlichem Saürstoffbedarf gerechnet werden. Da weder eine Impfung noch eine spezifische Therapie derzeit zur Verfügung stehen, müssen alle Massnahmen darauf ausgericht...et sein, die Verbreitung der Erkrankung so gut wie möglich zu verlangsamen. Es gibt 3 Komponenten: A) Verhinderung der Ausbreitung durch Fallfindung und Absonderung von engen Kontaktpersonen, B) soziale Distanz schaffen und C) gezielter Schutz von vulnerablen Gruppen, die aktiviert und intensiviert werden müssen ent-sprechend der jeweils aktuellen Lage
more
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...espread implementation remain. This document provides policy-makers and stakeholders with guidance on how to maximize the public health benefit of SARS-CoV-2 genomic sequencing activities in the short and long term as the pandemic continues to unfold. Practical considerations for the implementation of a virus genomic sequencing programme and an overview of the public health objectives of genomic sequencing are covered. This guidance focuses on SARS-CoV-2 but is applicable to other pathogens of public health concern.
more
Malaria Journal (2021) 20:190
This module should always be used together with the
mhGAP Intervention Guide for Mental, Neurological
and Substance Use Disorders in Non-specialized Health
Settings (WHO, 2010), which outlines relevant general
principles of care and management of a range of other
mental, neurological and substa...nce use disorders.
(www.who.int/mental_health/publications/mhGAP_
intervention_guide/en/index.html)
In the future, this module may be integrated with other
products in the following ways:
– This module may be integrated – in its full form –
into future iterations of the existing mhGAP Intervention
Guide.
– The module will be integrated –in a simplified structure –
into a new product, the WHO-UNHCR mhGAP Intervention
Guide for Humanitarian Settings (planned for 2014).
more
Practical Guidelines of Insulin Therapy in Diabetes Mellitus Patients
Hесмотря на многочисленные международные договоры и обязательства по защите прав мигрантов в области здравоохранения, эта ключевая затронутая группа населения п... прежнему испытывает серьезные затруднения в доступе к лечению от туберкулеза. Миграция вызвана рядом сложных экономических, социальных, политических и экологических факторов и является определяющим элементом плохого здоровья, а результаты лечения мигрантов находятся под воздействием различных измерений миграционного процесса.
Accessed on 2019
more
Der Policy Brief des Kompetenznetz Public Health COVID-19 befasst sich mit der empirischen Evidenz zu SARS-Cov-2 bei Migrant*innen und geflüchteten Menschen und leitet hieraus Handlungsempfehlungen ab. Eine Kernbotschaft des Papiers ist, dass das Risiko von SARS-CoV-2 Neuinfektionen unter Migrant*i...nnen im Vergleich zu Nicht-Migrant*innen höher ist, Krankenhauseinweisungen hingegen seltener sind.
more
Dürfen unbegleitete Minderjährige überhaupt abgeschoben werden? Was sind die Anforderungen an Behörden bei einer Abschiebung? Darf der Vormund bei einem Termin bei der Ausländerbehörde weggeschickt werden? Darf sich die Polizei zum Zweck der Abschiebung Zutritt zu einer Jugendhilfeeinrichtung ...verschaffen? Wie können sich die Jugendlichen und die betreuenden Fachkräfte wehren? Welche Besonderheiten gelten bei jungen Volljährigen? Zur Klärung dieser und vieler weiterer Fragen soll die neue Arbeitshilfe einen Beitrag leisten.
more
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian...ts; and (iv) how populations understand these dynamics, perceive risk and follow control measures, including public health and social measures (PHSM).
more